salicylic acid has been researched along with fluorouracil in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (7.81) | 18.7374 |
| 1990's | 4 (6.25) | 18.2507 |
| 2000's | 12 (18.75) | 29.6817 |
| 2010's | 32 (50.00) | 24.3611 |
| 2020's | 11 (17.19) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Amzel, LM; Gabelli, SB; Kinzler, KW; Maheshwari, S; McRobb, FM; Miller, MS; Vogelstein, B | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Goldfarb, MT; Gupta, AK; Gupta, MA; Sawchuk, WS | 1 |
| Anderson, FE | 1 |
| Michniak, BB; Phillips, CA | 1 |
| Danby, W | 1 |
| Smolinski, KN; Yan, AC | 1 |
| Davis, MD; Link, JS; Weick, JA | 1 |
| Cassano, R; La Mesa, C; Muzzalupo, R; Picci, N; Tavano, L; Trombino, S | 1 |
| Schlaak, M; Simon, JC | 1 |
| Gibbs, S; Holland, R; Kwok, CS | 1 |
| Kerl, H; Stockfleth, E; Willers, C; Zwingers, T | 1 |
| Ainsworth, C; Feigenbaum, AL; St Anna, L | 1 |
| Altinyazar, HC; Işik, S; Koca, R; Sarici, G | 1 |
| Dirschka, T; Dominicus, R; Karl, L; Rodríguez, R; Simon, JC; Willers, C | 1 |
| Brosa, M; Ferrándiz, C; Nieves, D; Plazas, MJ; Puig-Peiró, R | 1 |
| Alarcon, I; Malvehy, J; Puig, S; Ulrich, M | 1 |
| Kemmett, D; Nasr, R; Smethurst, H; Thybo, S; Tolley, K | 1 |
| Dirschka, T; Melzer, A; Prechtl, A; Szeimies, RM | 1 |
| Alarcon, I; Sibbring, GC; Stockfleth, E | 1 |
| Alarcon, I; Malvehy, J; Montoya, J; Puig, S; Rodríguez-Azeredo, R | 1 |
| Nguyen, HP; Rivers, JK | 1 |
| Azeredo, RR; Dirschka, T; Herranz, P; Morton, C; Roldán-Marín, R | 1 |
| Hadshiew, I; Melzer, A; Prechtl, A; Reinhold, U | 1 |
| Cai, JY; Chen, XF; Feng, J; Huang, C; Ling, Y; Liu, FT; Liu, J; Miao, JF; Niu, BX; Xu, QB; Zhang, Y | 1 |
| Falqués, M; Reinhold, U; Rodriguez Azeredo, R; Stockfleth, E; Ulrich, M | 1 |
| Goodhead, C; Hampton, P | 1 |
| Batalla, A; Flórez, A; Iglesias-Puzas, A; Suh-Oh, HJ | 1 |
| Bianchi, L; Campione, E; Diluvio, L; Lanna, C; Lozzi, F; Palumbo, V | 1 |
| Abeck, D; Biedermann, T; Lüftl, M; Tetsch, L | 1 |
| Blaszczak, A; Cartron, AM; Trinidad, JC | 1 |
| Benati, E; Condorelli, A; Cornacchia, L; Guiducci, L; Lai, M; Longo, C; Mirra, M; Pampena, R; Pellacani, G; Peris, K; Raucci, M | 1 |
| Acar, EM; Atasoy, M; Elmas, ÖF; Lotti, T; Özyurt, K; Türsen, Ü; Uyar, B | 1 |
| Ciccarese, G; Drago, F; Parodi, A | 1 |
| Bianchi, L; Campione, E; Cosio, T; Di Prete, M; Di Raimondo, C; Diluvio, L; Gaeta Shumak, R; Garofalo, V; Geraci, F; Lambiase, S; Lanna, C; Lozzi, F | 1 |
| Alessandrini, A; Bruni, F; Dika, E; Iorizzo, M; Piraccini, MB; Starace, M; Waśkiel-Burnat, A | 1 |
| Fu, S; Yu, Y; Zhang, G | 1 |
| Andersen, F; Bjerring, P; Haedersdal, M; Lerche, CM; Pihl, C | 1 |
| Kurka, M; Orfanos, CE; Pullmann, H | 1 |
| Stolte, M; Weidner, F | 1 |
| Krementz, ET; Litwin, MS; Reed, RJ; Ryan, RF | 1 |
| Baum, EW; Monheit, GD; Sams, WM | 1 |
| Bellman, B; Fountain, KS; Gregory, NA; Silvers, D | 1 |
| Liefers, GJ; Repelaer van Driel, OJ; Tollenaar, RA; van de Velde, CJ | 1 |
| Iwaki, M; Ogiso, T; Okajima, K; Shiraki, T; Tanino, T; Wada, T | 1 |
| Atkin, D; Fitzpatrick, R; Morhenn, V; Piacquadio, D; Smith, S | 1 |
| Lambert, T; Mullinax, K; Smith, J | 1 |
| Christianen, ME; Krekels, GA; Nelemans, P; Neumann, MH; Ostertag, JU; Quaedvlieg, PJ; van der Geer, S | 1 |
| Cooper, ZA; Hantash, BM; Koch, RJ; Rehmus, WE; Stewart, DB; Swetter, SM | 1 |
| Schmid-Wendtner, MH; Wendtner, CM | 1 |
| Beckford, A; Demierre, MF; Goldberg, L; Jalisi, S; Lerner, A; Ugent, S | 1 |
| Aiba, S; Fujimura, T; Haga, T; Hashimoto, A; Hidaka, T; Mizuashi, M; Onami, K; Watabe, A | 1 |
| Tallon, B; Turnbull, N | 1 |
| Jambusaria-Pahlajani, A; Liang, C; Ortman, S; Schmults, CD | 1 |
| Komen, MMC; Nortier, JWR; Smorenburg, CH; van den Hurk, CJG; van der Hoeven, JJM; van der Ploeg, T | 1 |
| Dewan, A; Fine, JD; Miller, JL | 1 |
| Komen, MMC; Nieboer, P; Nortier, JWR; Smorenburg, CH; van den Hurk, CJG; van der Hoeven, JJM; van der Ploeg, T | 1 |
| Fujii, T; Honda, C; Ichiba, K; Kurozumi, S; Nakazawa, Y; Obayashi, S; Ogino, M; Shirabe, K; Tokuda, S; Yajima, R | 1 |
| Heibloem, RE; Ilozumba, OUC; Komen, MMC; van den Hurk, CJG | 1 |
7 review(s) available for salicylic acid and fluorouracil
| Article | Year |
|---|---|
Warts. Fact and fiction.
Topics: Antiviral Agents; Bleomycin; Cryosurgery; Fluorouracil; Formaldehyde; Humans; Interferons; Papillomaviridae; Podophyllin; Psychotherapy; Retinoids; Salicylates; Salicylic Acid; Tumor Virus Infections; Warts; Wounds and Injuries | 1985 |
How and when to treat molluscum contagiosum and warts in children.
Topics: Adhesives; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Cantharidin; Child; Cimetidine; Cryotherapy; Curettage; Fluorouracil; Hot Temperature; Humans; Imiquimod; Immunotherapy; Irritants; Keratolytic Agents; Laser Therapy; Molluscum Contagiosum; Occlusive Dressings; Pediatrics; Podophyllin; Salicylic Acid; Tretinoin; Warts | 2005 |
Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antiviral Agents; Bleomycin; Cautery; Child; Cryotherapy; Dermatologic Agents; Fluorouracil; Humans; PUVA Therapy; Randomized Controlled Trials as Topic; Salicylic Acid; Skin Diseases; Treatment Outcome; Warts | 2011 |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Diterpenes; Drug Combinations; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Randomized Controlled Trials as Topic; Salicylic Acid; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Drug Combinations; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Salicylic Acid; Solutions | 2016 |
Improving the efficacy of photodynamic therapy for actinic keratosis: A comprehensive review of pharmacological pretreatment strategies.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Retinoids; Salicylic Acid; Treatment Outcome; Urea; Vitamin D | 2023 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Hypothermia, Induced; Middle Aged; Scalp; Time Factors | 1994 |
12 trial(s) available for salicylic acid and fluorouracil
| Article | Year |
|---|---|
Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Combinations; Female; Fluorouracil; Humans; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Pilot Projects; Salicylic Acid; Treatment Outcome | 2010 |
Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Hyaluronic Acid; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Salicylic Acid; Treatment Outcome | 2011 |
A comparison of a 5% potassium hydroxide solution with a 5-fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open-label clinical trial.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Condylomata Acuminata; Dermatologic Agents; Drug Combinations; Female; Fluorouracil; Humans; Hydroxides; Immunosuppressive Agents; Male; Potassium Compounds; Recurrence; Salicylic Acid | 2014 |
A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Cryosurgery; Drug Combinations; Facial Dermatoses; Female; Fluorouracil; Humans; Immunosuppressive Agents; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Prospective Studies; Recurrence; Salicylic Acid; Scalp; Severity of Illness Index; Treatment Outcome | 2015 |
Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Germany; Humans; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Salicylic Acid; Treatment Outcome | 2015 |
Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
Topics: Aged; Antimetabolites, Antineoplastic; Cohort Studies; Double-Blind Method; Female; Fluorouracil; Humans; Keratosis, Actinic; Male; Microscopy, Confocal; Pharmaceutical Vehicles; Salicylic Acid; Treatment Outcome | 2018 |
Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Hypothermia, Induced; Middle Aged; Scalp; Time Factors | 1994 |
Short incubation PDT versus 5-FU in treating actinic keratoses.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Face; Female; Fluorouracil; Humans; Keratosis; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Severity of Illness Index; Treatment Outcome | 2003 |
A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses.
Topics: Administration, Topical; Aged; Aged, 80 and over; Chi-Square Distribution; Face; Female; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Low-Level Light Therapy; Male; Middle Aged; Prospective Studies; Scalp; Treatment Outcome | 2006 |
Facial resurfacing for nonmelanoma skin cancer prophylaxis.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administration Schedule; Face; Female; Fluorouracil; Humans; Keratolytic Agents; Keratosis; Low-Level Light Therapy; Male; Middle Aged; Prospective Studies; Scalp; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Trichloroacetic Acid | 2006 |
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Hypothermia, Induced; Induction Chemotherapy; Middle Aged; Palliative Care; Prospective Studies; Scalp; Taxoids | 2019 |
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.
Topics: Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Hair; Humans; Hypothermia, Induced; Neoplasms; Paclitaxel; Registries; Scalp | 2023 |
46 other study(ies) available for salicylic acid and fluorouracil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design.
Topics: Allosteric Site; Class I Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Mutant Proteins; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Structure-Activity Relationship | 2017 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Office therapy for human papillomavirus infection in nongenital sites.
Topics: Bleomycin; Cantharidin; Caustics; Cryosurgery; Fluorouracil; Formaldehyde; Glutaral; Humans; Immunotherapy; Interferon Type I; Laser Therapy; Papillomaviridae; Podophyllin; Psychotherapy; Salicylates; Salicylic Acid; Tretinoin; Tumor Virus Infections | 1991 |
Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers.
Topics: Animals; Azepines; Caffeine; Drug Interactions; Fluorouracil; Hippurates; Hydrocortisone; Mice; Mice, Hairless; Salicylates; Salicylic Acid; Skin Absorption; Triamcinolone Acetonide | 1995 |
Treatment of porokeratosis with fluorouracil and salicylic acid under occlusion.
Topics: Administration, Cutaneous; Drug Therapy, Combination; Fluorouracil; Foot Dermatoses; Humans; Male; Middle Aged; Occlusive Dressings; Porokeratosis; Salicylic Acid | 2003 |
Response of predominantly recalcitrant cutaneous warts to topical chemotherapy.
Topics: Administration, Cutaneous; Deoxyglucose; Drug Therapy, Combination; Fluorouracil; Humans; Keratolytic Agents; Levamisole; Medical Records; Minnesota; Recurrence; Retrospective Studies; Salicylic Acid; Skin Diseases; Surveys and Questionnaires; Warts | 2006 |
Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Antioxidants; beta Carotene; Coumaric Acids; Drug Carriers; Drug Delivery Systems; Fluorouracil; Liposomes; Microscopy, Electron; Models, Chemical; Salicylic Acid; Surface-Active Agents | 2008 |
FPIN's clinical inquiries. Treatment of nongenital warts.
Topics: Antimetabolites, Antineoplastic; Cost-Benefit Analysis; Cryotherapy; Fluorouracil; Humans; Keratolytic Agents; Practice Guidelines as Topic; Salicylic Acid; United Kingdom; Warts | 2011 |
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
Topics: Antimetabolites, Antineoplastic; Cost-Benefit Analysis; Cryotherapy; Decision Support Techniques; Drug Combinations; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Quality-Adjusted Life Years; Salicylic Acid; Spain | 2015 |
In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dermatologic Agents; Female; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Male; Microscopy, Confocal; Middle Aged; Salicylic Acid; Skin Neoplasms | 2015 |
A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Topics: Cost-Benefit Analysis; Cryotherapy; Diclofenac; Diterpenes; Dose-Response Relationship, Drug; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Models, Econometric; Quality-Adjusted Life Years; Recurrence; Salicylic Acid; Scotland; Treatment Outcome | 2016 |
Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
Topics: Administration, Topical; Dermoscopy; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Image Enhancement; Immunosuppressive Agents; Keratolytic Agents; Keratosis, Actinic; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; Reproducibility of Results; Salicylic Acid; Tomography, Optical Coherence; Treatment Outcome | 2016 |
Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Topics: Administration, Topical; Clinical Trials as Topic; Drug Combinations; Fluorouracil; Humans; Keratosis, Actinic; Salicylic Acid; Solutions | 2016 |
Low-dose 5-fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms - results of a non-interventional study.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Fluorouracil; Forearm; Hand; Humans; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Salicylic Acid | 2017 |
Design, synthesis and biological evaluation of hybrids of β-carboline and salicylic acid as potential anticancer and apoptosis inducing agents.
Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Carbolines; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Design; Fluorouracil; Gene Expression Regulation, Neoplastic; Harmine; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Neoplasms; Salicylic Acid | 2016 |
Actikerall: an alternative to curettage for some seborrhoeic keratoses?
Topics: Aged; Antimetabolites; Drug Combinations; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Seborrheic; Off-Label Use; Salicylic Acid | 2018 |
0.5% 5-Fluorouracil/10% Salicylic Acid for the Treatment of Distal Actinic Keratoses Under Daily Practice Conditions
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Dermatologic Agents; Drug Combinations; Extremities; Female; Fluorouracil; Humans; Keratosis, Actinic; Male; Retrospective Studies; Salicylic Acid; Treatment Outcome | 2019 |
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
Topics: Adult; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Salicylic Acid; Skin Neoplasms; Solutions | 2019 |
Extragenital cutaneous warts - clinical presentation, diagnosis and treatment.
Topics: Acetates; Adult; Antiviral Agents; Cryotherapy; Curettage; Female; Fluorouracil; Formates; Humans; Laser Therapy; Male; Phototherapy; Salicylic Acid; Skin Diseases, Viral; Warts; Watchful Waiting | 2019 |
Combination therapy with 5-fluorouracil and salicylic acid in a treatment-resistant case of filiform facial warts.
Topics: Administration, Topical; Cryotherapy; Fluorouracil; Humans; Male; Salicylic Acid; Warts | 2020 |
Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy.
Topics: Dermoscopy; Fluorouracil; Humans; Keratosis, Actinic; Microscopy, Confocal; Salicylic Acid | 2020 |
Therapeutic efficacy and safety of three different modalities in pediatric patients with plantar warts.
Topics: Child; Cryotherapy; Fluorouracil; Humans; Retrospective Studies; Salicylic Acid; Treatment Outcome; Warts | 2021 |
5-Fluorouracil 0.5%/salicylic acid 10% solution in the treatment of ano-genital warts.
Topics: Adult; Condylomata Acuminata; Female; Fluorouracil; Humans; Imiquimod; Male; Pain; Salicylic Acid; Treatment Outcome; Warts | 2022 |
Early clinical response to 5-fluorouracil 0.5% and salicylic acid 10% topical solution in the treatment of actinic keratoses of the head: an observational study.
Topics: Fluorouracil; Humans; Keratosis, Actinic; Prospective Studies; Salicylic Acid; Treatment Outcome | 2022 |
Combination of topical fluorouracil and salicylic acid as a therapeutic option for recalcitrant warts of the nail unit.
Topics: Administration, Topical; Fluorouracil; Humans; Salicylic Acid; Treatment Outcome; Warts | 2023 |
Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Fluorouracil; Humans; Salicylic Acid; Skin Neoplasms | 2022 |
[Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil].
Topics: Aged; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Keratosis; Leukoplakia; Light; Lip Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Radiation-Induced; Precancerous Conditions; Scalp; Skin Neoplasms; Thorax; Tretinoin; Vitamin A | 1978 |
[Multicentric metatypical scalp basalioma (ulcus terebans) with perforation into the cranium].
Topics: Aged; Autopsy; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Palliative Care; Scalp; Skin Neoplasms; Skull Neoplasms | 1974 |
Topical chemotherapy of cutaneous malignancy of the head and neck.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Humans; Keratosis; Ointments; Scalp; Skin Neoplasms | 1969 |
Angiolymphoid hyperplasia with eosinophilia. The disease and a comparison of treatment modalities.
Topics: Biopsy; Bleomycin; Cryosurgery; Eosinophilic Granuloma; Female; Fluorouracil; Humans; Microscopy, Electron; Middle Aged; Scalp; Scalp Dermatoses; Vinblastine | 1982 |
Sweat gland carcinoma with metastases to the skin: response to 5-fluorouracil chemotherapy.
Topics: Aged; Bone Marrow Diseases; Bone Neoplasms; Carcinoma, Signet Ring Cell; Facial Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Orbital Neoplasms; Scalp; Skin Neoplasms; Sweat Gland Neoplasms; Thoracic Neoplasms | 1995 |
Transfollicular drug delivery: penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro.
Topics: Abdomen; Acyclovir; Administration, Cutaneous; Adult; Drug Delivery Systems; Female; Fluorouracil; Hair Follicle; Humans; In Vitro Techniques; Ketoprofen; Male; Melatonin; Middle Aged; Scalp; Skin Absorption | 2002 |
A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
Topics: Administration, Cutaneous; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Male; Scalp; Skin Neoplasms; Skin Ulcer | 2006 |
Intensified inflammatory reaction of actinic keratoses after single application of topical 5-fluorouracil in a patient treated with nilotinib for chronic myeloid leukemia.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Dermatologic Agents; Drug Therapy, Combination; Fluorouracil; Forehead; Humans; Keratosis, Actinic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Scalp; Time Factors; Treatment Outcome | 2009 |
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.
Topics: Acrospiroma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Male; Remission Induction; Scalp; Sweat Gland Neoplasms | 2011 |
Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Capecitabine; Carcinoma; Deoxycytidine; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lapatinib; Liver Neoplasms; Male; Middle Aged; Quinazolines; Receptor, ErbB-2; Scalp; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Bandages; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Leg; Scalp; Skin Neoplasms | 2013 |
Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Facial Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Risk Factors; Scalp; Skin Neoplasms; Treatment Outcome | 2016 |
Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
Topics: Adult; Aged; Alopecia; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cryotherapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Scalp; Skin Temperature | 2016 |
Occurrence of Acute Cerebellar Syndrome After Topical Application of Fluorouracil.
Topics: Acute Disease; Administration, Topical; Cerebellar Diseases; Fluorouracil; Humans; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Scalp; Scalp Dermatoses | 2017 |
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
Topics: Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Epirubicin; Eyebrows; Eyelashes; Female; Fluorouracil; Humans; Japan; Middle Aged; Premenopause; Prevalence; Prospective Studies; Scalp; Self Report; Taxoids; Treatment Outcome | 2021 |